Shifting the focus – the primary role of IL‐23 in psoriasis and other inflammatory disorders
Open Access
- 9 March 2018
- journal article
- review article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 32 (7), 1111-1119
- https://doi.org/10.1111/jdv.14868
Abstract
Insights into the pathophysiology of autoimmune inflammatory diseases including psoriasis have advanced considerably in recent years, and in parallel, so too have the available treatment options. Current clinical paradigms for the treatment of psoriasis have evolved to include targeted biologic therapies, starting with tumor necrosis factor-alpha (TNF-α) inhibitors and later, agents targeting interleukin (IL)-12/23 and IL-17. The most recent evidence suggests that IL-23 might be an even more potent target for the effective treatment of psoriasis and other autoimmune inflammatory disorders. This review will describe recent developments leading to the current understanding of the key role of IL-23 as a ‘master regulator’ of autoimmune inflammation, and the clinical evidence for agents that specifically target this modulator in the context of treating psoriasis, spondyloarthropathy, and inflammatory bowel disease.Keywords
Funding Information
- Janssen Inc.
This publication has 97 references indexed in Scilit:
- Human T H 17 Cells Are Long-Lived Effector Memory CellsScience Translational Medicine, 2011
- Psoriasis: what we have learned from mouse modelsNature Reviews Rheumatology, 2010
- Polymorphisms of the IL12B and IL23R Genes Are Associated with PsoriasisJournal of Investigative Dermatology, 2008
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)The Lancet, 2008
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)The Lancet, 2008
- Development, cytokine profile and function of human interleukin 17–producing helper T cellsNature Immunology, 2007
- IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk GenesAmerican Journal of Human Genetics, 2007
- Interleukin-23 drives innate and T cell–mediated intestinal inflammationThe Journal of Experimental Medicine, 2006
- The IL-23/IL-17 axis in inflammationJCI Insight, 2006